title: Iron absorption in male C282Y heterozygotes.
abstract: BACKGROUND
  The suggestion that carriers of the HFE C282Y mutation absorb nonheme iron more efficiently than do carriers of the wild type has public health implications for countries where the C282Y mutation is common and foods are fortified with iron.
  
  
  OBJECTIVE
  We investigated the effect of C282Y heterozygosity on nonheme-iron absorption from a diet high in bioavailable iron and from iron-fortified cereals.
  
  
  METHODS
  The subjects were recruited from a parallel study investigating the relation between HFE mutations, habitual diet, and iron status. Iron absorption was measured in 15 wild-type carriers and 15 C282Y heterozygotes aged >/=40 y. Each subject consumed 3 meals of high iron bioavailability (labeled with Fe-57) for 2 d and 2 meals with fortified cereal products (labeled with Fe-54) for the next 3 d. Iron absorption was measured from isotope incorporation into red blood cells 14 d after the last labeled meal and was corrected for utilization of absorbed iron by means of an intravenous infusion of Fe-58.
  
  
  RESULTS
  Absorption of Fe-57 with the high-iron-bioavailability diet was 6.8 +/- 6.8% (0.6 +/- 0.6 mg/d) in the wild-type carriers and 7.6 +/- 3.2% (0.7 +/- 0.3 mg/d) in the C282Y heterozygotes. Absorption of Fe-54 with cereal products was 4.9 +/- 2.0% (0.7 +/- 0.3 mg/d) in the wild-type carriers and 5.3 +/- 1.3% (0.8 +/- 0.2 mg/d) in the C282Y heterozygotes.
  
  
  CONCLUSIONS
  There was no overall significant difference between C282Y heterozygotes and wild-type men in iron absorption from either dietary nonheme iron or fortified cereal products.
authors.affiliation: Institute of Food Research, Norwich Research Park, Norwich, United Kingdom.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Roe
authors.forename: Anne-Louise M
authors.initials: AL
authors.lastname: Heath
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Oyston
authors.forename: Cate
authors.initials: C
authors.lastname: Macrow
authors.forename: Jurian A
authors.initials: JA
authors.lastname: Hoogewerff
authors.forename: Rob
authors.initials: R
authors.lastname: Foxall
authors.forename: Jack R
authors.initials: JR
authors.lastname: Dainty
authors.forename: Gosia
authors.initials: G
authors.lastname: Majsak-Newman
authors.forename: Gavin
authors.initials: G
authors.lastname: Willis
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Fairweather-Tait
mesh_terms: D001682:Biological Availability; D004032:Diet; D005293:Ferritins / Q000097:blood; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D007408:Intestinal Absorption / Q000235:genetics*; D019266:Iron, Dietary / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged
chemical_list: D019266:Iron, Dietary; D005293:Ferritins